IVD News and Research

RSS
Rapidly growing nanotechnology firm launches new identity as MIP Discovery

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

The Nucleic Acid Experts – Certified Twice!

The Nucleic Acid Experts – Certified Twice!

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Expanded range of nucleic acid extraction kits for pathogens detection

Expanded range of nucleic acid extraction kits for pathogens detection

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

New research sheds light on the working principles of advanced biosensing technologies

New research sheds light on the working principles of advanced biosensing technologies